CME Medical Grand Rounds ~ Targeted Therapy in Triple Negative Breast Cancer: Current Progress and F

EVENT DETAILS AND REGISTRATION

Date:September 13, 2016

Time: 12:00 PM - 01:00 PM (PT)

Location:Conference Room B

Event Is:

  • Examine the current evidence for the use of androgen receptor, PI3K/mTOR, immune checkpoint inhibitors in triple negative breast cancers
  • Discuss biologic rationale and candidate biomarkers that predict for benefit of targeted therapy and/or immunotherapies in triple negative breast cancer
  • Outline trials both ongoing and in development evaluating AR, PI3K/mTOR,  immunotherapy approaches in triple negative breast cancer

Presenters:Yuan Yuan, MD, PhD

ADDITIONAL DETAILS:

Objectives:

  • Examine the current evidence for the use of androgen receptor, PI3K/mTOR, immune checkpoint inhibitors in triple negative breast cancers
  • Discuss biologic rationale and candidate biomarkers that predict for benefit of targeted therapy and/or immunotherapies in triple negative breast cancer
  • Outline trials both ongoing and in development evaluating AR, PI3K/mTOR,  immunotherapy approaches in triple negative breast cancer

Who should attend:

Physicians, advanced care practitioners, nurses, pharmacists and all other allied healthcare professionals interested in the subject matter

CME credits:1.0 AMA/PRA Category 1 Credit™ The City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. City of Hope designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.TM

R.S.V.P.: First Come First Serve

Contact:

CME Department